Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-18-004427
Filing Date
2018-06-13
Accepted
2018-06-13 16:50:45
Documents
1
Period of Report
2018-01-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-41257.html 3  
1 PRIMARY DOCUMENT marketforms-41257.xml 3 4224
  Complete submission text file 0001214659-18-004427.txt   5670
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
Intiva BioPharma Inc. (Issuer) CIK: 0001625288 (see all company filings)

EIN.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 408 BARBARA LANE BRYN MAWR PA 19010
Business Address
Snider Lindy (Reporting) CIK: 0001733367 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55320 | Film No.: 18897223